NM_006096.4:c.450+61A>G

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_006096.4(NDRG1):​c.450+61A>G variant causes a intron change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.275 in 1,520,300 control chromosomes in the GnomAD database, including 59,636 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.29 ( 6922 hom., cov: 32)
Exomes 𝑓: 0.27 ( 52714 hom. )

Consequence

NDRG1
NM_006096.4 intron

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: 0.187

Publications

10 publications found
Variant links:
Genes affected
NDRG1 (HGNC:7679): (N-myc downstream regulated 1) This gene is a member of the N-myc downregulated gene family which belongs to the alpha/beta hydrolase superfamily. The protein encoded by this gene is a cytoplasmic protein involved in stress responses, hormone responses, cell growth, and differentiation. The encoded protein is necessary for p53-mediated caspase activation and apoptosis. Mutations in this gene are a cause of Charcot-Marie-Tooth disease type 4D, and expression of this gene may be a prognostic indicator for several types of cancer. Alternatively spliced transcript variants encoding multiple isoforms have been observed for this gene. [provided by RefSeq, May 2012]
NDRG1 Gene-Disease associations (from GenCC):
  • Charcot-Marie-Tooth disease type 4D
    Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Orphanet, Labcorp Genetics (formerly Invitae), Illumina

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.78).
BP6
Variant 8-133258305-T-C is Benign according to our data. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr8-133258305-T-C is described in CliVar as Benign. Clinvar id is 670539.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.348 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NDRG1NM_006096.4 linkc.450+61A>G intron_variant Intron 7 of 15 ENST00000323851.13 NP_006087.2 Q92597-1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NDRG1ENST00000323851.13 linkc.450+61A>G intron_variant Intron 7 of 15 1 NM_006096.4 ENSP00000319977.8 Q92597-1

Frequencies

GnomAD3 genomes
AF:
0.295
AC:
44785
AN:
151964
Hom.:
6908
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.352
Gnomad AMI
AF:
0.465
Gnomad AMR
AF:
0.313
Gnomad ASJ
AF:
0.322
Gnomad EAS
AF:
0.0598
Gnomad SAS
AF:
0.262
Gnomad FIN
AF:
0.217
Gnomad MID
AF:
0.342
Gnomad NFE
AF:
0.284
Gnomad OTH
AF:
0.304
GnomAD4 exome
AF:
0.273
AC:
373725
AN:
1368218
Hom.:
52714
AF XY:
0.273
AC XY:
185015
AN XY:
678654
show subpopulations
African (AFR)
AF:
0.361
AC:
11370
AN:
31488
American (AMR)
AF:
0.298
AC:
11109
AN:
37232
Ashkenazi Jewish (ASJ)
AF:
0.327
AC:
8198
AN:
25052
East Asian (EAS)
AF:
0.0752
AC:
2829
AN:
37612
South Asian (SAS)
AF:
0.271
AC:
21534
AN:
79566
European-Finnish (FIN)
AF:
0.223
AC:
11192
AN:
50080
Middle Eastern (MID)
AF:
0.355
AC:
2001
AN:
5638
European-Non Finnish (NFE)
AF:
0.278
AC:
289891
AN:
1044442
Other (OTH)
AF:
0.273
AC:
15601
AN:
57108
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.503
Heterozygous variant carriers
0
14064
28128
42193
56257
70321
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
9668
19336
29004
38672
48340
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.295
AC:
44843
AN:
152082
Hom.:
6922
Cov.:
32
AF XY:
0.290
AC XY:
21588
AN XY:
74350
show subpopulations
African (AFR)
AF:
0.352
AC:
14611
AN:
41452
American (AMR)
AF:
0.313
AC:
4785
AN:
15294
Ashkenazi Jewish (ASJ)
AF:
0.322
AC:
1118
AN:
3472
East Asian (EAS)
AF:
0.0596
AC:
309
AN:
5188
South Asian (SAS)
AF:
0.263
AC:
1265
AN:
4810
European-Finnish (FIN)
AF:
0.217
AC:
2300
AN:
10582
Middle Eastern (MID)
AF:
0.354
AC:
104
AN:
294
European-Non Finnish (NFE)
AF:
0.284
AC:
19293
AN:
67970
Other (OTH)
AF:
0.301
AC:
636
AN:
2112
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
1620
3240
4860
6480
8100
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
458
916
1374
1832
2290
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.288
Hom.:
24058
Bravo
AF:
0.304
Asia WGS
AF:
0.188
AC:
657
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:2
Jun 14, 2018
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Charcot-Marie-Tooth disease type 4D Benign:1
Jul 10, 2021
Genome-Nilou Lab
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.78
CADD
Benign
6.3
DANN
Benign
0.75
PhyloP100
0.19
PromoterAI
0.017
Neutral
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs2272651; hg19: chr8-134270548; API